A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(2 sites)

China

Beijing Chest Hospital affiliated to Capital Medical University, Beijing, Beijing Municipality

Beijing Chest Hospital, Capital Medical University, Beijing, Beijing Municipality